Tito Fojo talks to ecancer at EAPM 2017 in Belfast.

He was asked to speak at the conference to provide an alternate and opposing view to personalised medicine. 

He believes that we are not ready to start personalising lots of individual patients. 

Lack of knowledge and extrapolation of data worries him, and he thinks that we could cause more damage than good if we jump the gun.

He sheds light on the amount of data lost through personalising treatments without capturing the data during the process.